We are live on
!
Find out more
ONC
BeOne Medicines Ltd
227 hedge funds and large institutions have $8.07B invested in BeOne Medicines Ltd in 2024 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 78 increasing their positions, 78 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
20% more call options, than puts
Call options by funds: $27.1M | Put options by funds: $22.6M
9% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 32
0% more funds holding
Funds holding: 227 → 227 (0)
0% more repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 78
0.23% less ownership
Funds ownership: 3.73% → 3.5% (-0.23%)
23% less capital invested
Capital invested by funds: $10.4B → $8.07B (-$2.38B)
40% less funds holding in top 10
Funds holding in top 10: 10 → 6 (-4)
Holders
227
Holders Change
–
Holders Change %
0%
% of All Funds
2.99%
Holding in Top 10
6
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-40%
% of All Funds
0.08%
New
35
Increased
78
Reduced
78
Closed
32
Calls
$27.1M
Puts
$22.6M
Net Calls
+$4.45M
Net Calls Change
-$34.4M
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$115M |
| 2 |
PBA
Paradigm Biocapital Advisors
New York
|
+$84.9M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$55.2M |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
+$49.6M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$48.4M |
